Renal function, renal volume, and blood pressure in infants with antecedent of antenatal steroids

Deyanira Carballo-Magdaleno1, Juan M Guízar-Mendoza, Norma Amador-Licona

  • 1Unidad Médica de Alta Especialidad No. 48, Instituto Mexicano del Seguro Social, Leon, Guanajuato, Mexico.

Insights

Prematurity, not antenatal steroid use, is linked to higher blood pressure and kidney function in infants. This study found no significant differences between preterm infants who received steroids and those who did not.

Area of Science:

  • Neonatal Medicine
  • Pediatric Nephrology
  • Endocrinology

Background:

  • Antenatal steroid administration is used to promote pulmonary maturity in preterm infants.
  • Potential long-term adverse effects include insulin resistance and elevated blood pressure.

Purpose of the Study:

  • To compare renal volume, function, and blood pressure in infants aged 12-36 months.
  • To assess the impact of antenatal steroid treatment versus prematurity itself.

Main Methods:

  • Cross-sectional study involving three groups: preterm infants with antenatal steroids, preterm infants without, and full-term infants (30 per group).
  • Measurements included blood pressure, renal volume, glomerular filtration rate (GFR), and tubular function.
  • Cystatin C levels were used to assess GFR.

Main Results:

  • Both preterm groups showed higher blood pressure, cystatin C levels, and GFR compared to the full-term control group (p < 0.01).
  • No significant differences were observed in measured variables between preterm infants who received antenatal steroids and those who did not.
  • Renal volume was comparable between preterm and full-term infants.

Conclusions:

  • Prematurity, independent of antenatal steroid exposure, is associated with elevated cystatin C, higher blood pressure, and increased GFR in infants aged 12-36 months.
  • Antenatal steroid treatment did not appear to significantly alter these specific renal and cardiovascular parameters by 12-36 months of age.

Related Concept Videos

Hormonal Regulation01:33

Hormonal Regulation

The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.